Erbitux (IMC-C225) plus weekly irinotecan (CPT-11), fluorouracil (5FU) and leucovorin (LV) in colorectal cancer (CRC) that expresses the epidermal growth factor receptor (EGFr). - Rosenberg,A.H.; Loehrer,P.J.; Needle,M.N. (ASCO, 2002)